Viewing Study NCT02412267


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-05-02 @ 6:54 AM
Study NCT ID: NCT02412267
Status: COMPLETED
Last Update Posted: 2016-03-23
First Post: 2015-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor: National Cancer Centre, Singapore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
Keywords: